These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2188364)

  • 21. Animal models for breast cancer.
    Sukumar S; McKenzie K; Chen Y
    Mutat Res; 1995 Dec; 333(1-2):37-44. PubMed ID: 8538634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An experimental analysis of cancer: role of ras oncogenes in multistep carcinogenesis.
    Sukumar S
    Cancer Cells; 1990 Jul; 2(7):199-204. PubMed ID: 2204384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas.
    Sukumar S; Carney WP; Barbacid M
    Science; 1988 Apr; 240(4851):524-6. PubMed ID: 3282307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
    Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis.
    Bera TK; Guzman RC; Miyamoto S; Panda DK; Sasaki M; Hanyu K; Enami J; Nandi S
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9789-93. PubMed ID: 7937892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of mammary carcinomas by N-methyl-N-nitrosourea in ovariectomized rats treated with epidermal growth factor.
    Chou YC; Guzman RC; Swanson SM; Yang J; Lui HM; Wu V; Nandi S
    Carcinogenesis; 1999 Apr; 20(4):677-84. PubMed ID: 10223199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
    Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.
    Asamoto M; Ota T; Toriyama-Baba H; Hokaiwado N; Naito A; Tsuda H
    Jpn J Cancer Res; 2002 Jan; 93(1):32-5. PubMed ID: 11802805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels.
    Zhang R; Haag JD; Gould MN
    Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
    Ogawa K; Tokusashi Y; Fukuda I
    Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ras activation in experimental carcinogenesis.
    Mangues R; Pellicer A
    Semin Cancer Biol; 1992 Aug; 3(4):229-39. PubMed ID: 1421167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.
    Stanley LA
    Toxicology; 1995 Feb; 96(3):173-94. PubMed ID: 7900159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues.
    Ballin M; Mackay AR; Hartzler JL; Nason A; Pelina MD; Thorgeirsson UP
    Clin Exp Metastasis; 1991; 9(2):179-89. PubMed ID: 2032422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.
    Tsukamoto T; Huang T; Guzman RC; Chen X; Pascual RV; Kitamura T; Nandi S
    Biochem Biophys Res Commun; 1999 Nov; 265(1):7-12. PubMed ID: 10548482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.
    Gould MN; Moore CJ; Zhang R; Wang B; Kennan WS; Haag JD
    Cancer Res; 1994 Jul; 54(13):3540-3. PubMed ID: 8012978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential methylation of the Ha-ras proto-oncogene by methylnitrosourea in rat mammary glands.
    Lu SJ; Milligan JR; Archer MC
    Mol Carcinog; 1991; 4(4):261-4. PubMed ID: 1714738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible role of activated ras genes in human esophageal carcinogenesis.
    Galiana C; Fusco A; Martel N; Nishihira T; Hirohashi S; Yamasaki H
    Int J Cancer; 1993 Jul; 54(6):978-82. PubMed ID: 8335405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat.
    Lu J; Jiang C; Mitrenga T; Cutter G; Thompson HJ
    Carcinogenesis; 1998 Jan; 19(1):223-7. PubMed ID: 9472716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.